title: Debated Role of Ovarian Protection With Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Women With Cancer.
authors.affiliation: Matteo Lambertini, Breast Adjuvant Study Team Data Centre, Institut Jules Bordet, and Université Libre de Bruxelles, Brussels, Belgium; Tommaso Falcone, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH; Joseph M. Unger, Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA; Kelly-Anne Phillips, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Lucia Del Mastro, Istituto di Ricovero e Cura a Carattere Scientifico-Azienda Ospedaliera Universitaria San Martino-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy; and Halle C.F. Moore, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH.
authors.forename: Matteo
authors.initials: M
authors.lastname: Lambertini
authors.affiliation: Matteo Lambertini, Breast Adjuvant Study Team Data Centre, Institut Jules Bordet, and Université Libre de Bruxelles, Brussels, Belgium; Tommaso Falcone, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH; Joseph M. Unger, Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA; Kelly-Anne Phillips, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Lucia Del Mastro, Istituto di Ricovero e Cura a Carattere Scientifico-Azienda Ospedaliera Universitaria San Martino-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy; and Halle C.F. Moore, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH.
authors.forename: Tommaso
authors.initials: T
authors.lastname: Falcone
authors.affiliation: Matteo Lambertini, Breast Adjuvant Study Team Data Centre, Institut Jules Bordet, and Université Libre de Bruxelles, Brussels, Belgium; Tommaso Falcone, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH; Joseph M. Unger, Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA; Kelly-Anne Phillips, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Lucia Del Mastro, Istituto di Ricovero e Cura a Carattere Scientifico-Azienda Ospedaliera Universitaria San Martino-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy; and Halle C.F. Moore, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH.
authors.forename: Joseph M
authors.initials: JM
authors.lastname: Unger
authors.affiliation: Matteo Lambertini, Breast Adjuvant Study Team Data Centre, Institut Jules Bordet, and Université Libre de Bruxelles, Brussels, Belgium; Tommaso Falcone, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH; Joseph M. Unger, Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA; Kelly-Anne Phillips, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Lucia Del Mastro, Istituto di Ricovero e Cura a Carattere Scientifico-Azienda Ospedaliera Universitaria San Martino-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy; and Halle C.F. Moore, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH.
authors.forename: Kelly-Anne
authors.initials: KA
authors.lastname: Phillips
authors.affiliation: Matteo Lambertini, Breast Adjuvant Study Team Data Centre, Institut Jules Bordet, and Université Libre de Bruxelles, Brussels, Belgium; Tommaso Falcone, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH; Joseph M. Unger, Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA; Kelly-Anne Phillips, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Lucia Del Mastro, Istituto di Ricovero e Cura a Carattere Scientifico-Azienda Ospedaliera Universitaria San Martino-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy; and Halle C.F. Moore, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH.
authors.forename: Lucia
authors.initials: L
authors.lastname: Del Mastro
authors.affiliation: Matteo Lambertini, Breast Adjuvant Study Team Data Centre, Institut Jules Bordet, and Université Libre de Bruxelles, Brussels, Belgium; Tommaso Falcone, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH; Joseph M. Unger, Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA; Kelly-Anne Phillips, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Lucia Del Mastro, Istituto di Ricovero e Cura a Carattere Scientifico-Azienda Ospedaliera Universitaria San Martino-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy; and Halle C.F. Moore, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH.
authors.forename: Halle C F
authors.initials: HC
authors.lastname: Moore
mesh_terms: D005260:Female; D005298:Fertility; D007987:Gonadotropin-Releasing Hormone; D006801:Humans; D008223:Lymphoma; D009369:Neoplasms; D011446:Prospective Studies; D017741:Survivors
chemical_list: D007987:Gonadotropin-Releasing Hormone